Trials / Unknown
UnknownNCT04761978
Efficacy and Tolerance of JAK Inhibitors in ATU for Atopic Dermatitis
Effectiveness and Safety of JAK Inhibitors for the Treatment of Moderate-to-severe Atopic Dermatitis in a Real-life French Multicenter Adult Cohort
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (estimated)
- Sponsor
- University Hospital, Lille · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The aim is to assess effectiveness (EASI, SCORAD, IGA, DLQI, pruritus, sleep loss) and safety (clinical and biological adverse events) of JAK inhibitors in adults with moderate-to-severe atopic dermatitis in a real-life French multicenter retrospective cohort
Conditions
Timeline
- Start date
- 2021-09-01
- Primary completion
- 2022-09-01
- Completion
- 2022-09-01
- First posted
- 2021-02-21
- Last updated
- 2021-05-28
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04761978. Inclusion in this directory is not an endorsement.